Company / Assets per Share
Larimar Therapeutics, Inc. Assets per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.17
FY2019
5-year range
$2.17 / $8.27
FY2015-FY2019
Trend
-51.1%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.86 to $2.17 over the past 2 years.
Based on SEC 10-K filings.
2.17 in FY2019 with a 5-year CAGR of -57.8%.
Declined from $3.86 to $2.17 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -23.5%
- 5-Year CAGR
- -57.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, assets per share decreased 51.1% year-over-year.
- Peak assets per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $2.17 | -51.1% |
| FY2018 | $4.43 | +14.7% |
| FY2017 | $3.86 | -20.1% |
| FY2016 | $4.83 | -41.5% |
| FY2015 | $8.27 | -94.9% |
| FY2014 | $161.12 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026